Literature DB >> 25667419

Functional characterization of enzymes catalyzing ceramide phosphoethanolamine biosynthesis in mice.

Andreas Bickert1, Christina Ginkel1, Matthijs Kol2, Katharina vom Dorp3, Holger Jastrow4, Joachim Degen1, René L Jacobs5, Dennis E Vance6, Elke Winterhager7, Xian-Cheng Jiang8, Peter Dörmann3, Pentti Somerharju9, Joost C M Holthuis2, Klaus Willecke1.   

Abstract

Besides bulk amounts of SM, mammalian cells produce small quantities of the SM analog ceramide phosphoethanolamine (CPE). Little is known about the biological role of CPE or enzymes responsible for CPE production. Heterologous expression studies revealed that SM synthase (SMS)2 is a bifunctional enzyme producing both SM and CPE, whereas SMS-related protein (SMSr) serves as monofunctional CPE synthase. Acute disruption of SMSr catalytic activity in cultured cells causes a rise in endoplasmic reticulum (ER) ceramides, fragmentation of ER exit sites, and induction of mitochondrial apoptosis. To address the relevance of CPE biosynthesis in vivo, we analyzed the tissue-specific distribution of CPE in mice and generated mouse lines lacking SMSr and SMS2 catalytic activity. We found that CPE levels were >300-fold lower than SM in all tissues examined. Unexpectedly, combined inactivation of SMSr and SMS2 significantly reduced, but did not eliminate, tissue-specific CPE pools and had no obvious impact on mouse development or fertility. While SMSr is widely expressed and serves as the principal CPE synthase in the brain, blocking its catalytic activity did not affect ceramide levels or secretory pathway integrity in the brain or any other tissue. Our data provide a first inventory of CPE species and CPE-biosynthetic enzymes in mammals.
Copyright © 2015 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  brain lipids; enzyme inactivation; genetics; mass spectrometry; sphingolipids; sphingomyelin synthase; sphingomyelin synthase-related protein; sterile α motif domain-containing protein 8; transgenic mice

Mesh:

Substances:

Year:  2015        PMID: 25667419      PMCID: PMC4373740          DOI: 10.1194/jlr.M055269

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  47 in total

Review 1.  De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway.

Authors:  Alfred H Merrill
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

2.  Impaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesity.

Authors:  René L Jacobs; Yang Zhao; Debby P Y Koonen; Torunn Sletten; Brian Su; Susanne Lingrell; Guoqing Cao; David A Peake; Ming-Shang Kuo; Spencer D Proctor; Brian P Kennedy; Jason R B Dyck; Dennis E Vance
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

Review 3.  The multigenic sphingomyelin synthase family.

Authors:  Fikadu Geta Tafesse; Philipp Ternes; Joost C M Holthuis
Journal:  J Biol Chem       Date:  2006-08-11       Impact factor: 5.157

4.  Mitochondrial dysfunction and increased reactive oxygen species impair insulin secretion in sphingomyelin synthase 1-null mice.

Authors:  Masato Yano; Ken Watanabe; Tadashi Yamamoto; Kazutaka Ikeda; Takafumi Senokuchi; Meihong Lu; Tsuyoshi Kadomatsu; Hiroto Tsukano; Masahito Ikawa; Masaru Okabe; Shohei Yamaoka; Toshiro Okazaki; Hisanori Umehara; Tomomi Gotoh; Wen-Jie Song; Koichi Node; Ryo Taguchi; Kazuya Yamagata; Yuichi Oike
Journal:  J Biol Chem       Date:  2010-11-29       Impact factor: 5.157

5.  The effect of sphingomyelin synthase 2 (SMS2) deficiency on the expression of drug transporters in mouse brain.

Authors:  Yu Zhang; Jibin Dong; Xingang Zhu; Weirong Wang; Qing Yang
Journal:  Biochem Pharmacol       Date:  2011-04-30       Impact factor: 5.858

6.  Identification of a family of animal sphingomyelin synthases.

Authors:  Klazien Huitema; Joep van den Dikkenberg; Jos F H M Brouwers; Joost C M Holthuis
Journal:  EMBO J       Date:  2003-12-18       Impact factor: 11.598

7.  Ceramide phosphoethanolamine biosynthesis in Drosophila is mediated by a unique ethanolamine phosphotransferase in the Golgi lumen.

Authors:  Ana M Vacaru; Joep van den Dikkenberg; Philipp Ternes; Joost C M Holthuis
Journal:  J Biol Chem       Date:  2013-02-28       Impact factor: 5.157

8.  Inducible Cre mice.

Authors:  Susanne Feil; Nadejda Valtcheva; Robert Feil
Journal:  Methods Mol Biol       Date:  2009

9.  Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice.

Authors:  Zhiqiang Li; Yifan Fan; Jing Liu; Yan Li; Chongmin Huan; Hai H Bui; Ming-Shang Kuo; Tae-Sik Park; Guoqing Cao; Xian-Cheng Jiang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-10       Impact factor: 8.311

10.  Sphingomyelin synthase-related protein SMSr controls ceramide homeostasis in the ER.

Authors:  Ana M Vacaru; Fikadu G Tafesse; Philipp Ternes; Vangelis Kondylis; Martin Hermansson; Jos F H M Brouwers; Pentti Somerharju; Catherine Rabouille; Joost C M Holthuis
Journal:  J Cell Biol       Date:  2009-06-08       Impact factor: 10.539

View more
  14 in total

1.  Diacylglycerol kinase δ and sphingomyelin synthase-related protein functionally interact via their sterile α motif domains.

Authors:  Chiaki Murakami; Fumi Hoshino; Hiromichi Sakai; Yasuhiro Hayashi; Atsushi Yamashita; Fumio Sakane
Journal:  J Biol Chem       Date:  2020-01-24       Impact factor: 5.157

2.  Switching head group selectivity in mammalian sphingolipid biosynthesis by active-site engineering of sphingomyelin synthases.

Authors:  Matthijs Kol; Radhakrishnan Panatala; Mirjana Nordmann; Leoni Swart; Leonie van Suijlekom; Birol Cabukusta; Angelika Hilderink; Tanja Grabietz; John G M Mina; Pentti Somerharju; Sergei Korneev; Fikadu G Tafesse; Joost C M Holthuis
Journal:  J Lipid Res       Date:  2016-05-10       Impact factor: 5.922

3.  Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes.

Authors:  Tove Fall; Samira Salihovic; Stefan Brandmaier; Christoph Nowak; Andrea Ganna; Stefan Gustafsson; Corey D Broeckling; Jessica E Prenni; Gabi Kastenmüller; Annette Peters; Patrik K Magnusson; Rui Wang-Sattler; Vilmantas Giedraitis; Christian Berne; Christian Gieger; Nancy L Pedersen; Erik Ingelsson; Lars Lind
Journal:  Diabetologia       Date:  2016-07-12       Impact factor: 10.122

4.  Switching head group selectivity in mammalian sphingolipid biosynthesis by active-site-engineering of sphingomyelin synthases.

Authors:  Matthijs Kol; Radhakrishnan Panatala; Mirjana Nordmann; Leoni Swart; Leonie van Suijlekom; Birol Cabukusta; Angelika Hilderink; Tanja Grabietz; John G M Mina; Pentti Somerharju; Sergei Korneev; Fikadu G Tafesse; Joost C M Holthuis
Journal:  J Lipid Res       Date:  2017-03-23       Impact factor: 5.922

5.  Sphingomyelin Synthase Family and Phospholipase Cs.

Authors:  Xian-Cheng Jiang; Yeun-Po Chiang
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

6.  A search for ceramide binding proteins using bifunctional lipid analogs yields CERT-related protein StarD7.

Authors:  Svenja Bockelmann; John G M Mina; Sergei Korneev; Dina G Hassan; Dagmar Müller; Angelika Hilderink; Hedwich C Vlieg; Reinout Raijmakers; Albert J R Heck; Per Haberkant; Joost C M Holthuis
Journal:  J Lipid Res       Date:  2018-01-17       Impact factor: 5.922

Review 7.  Sphingolipids as Regulators of Neuro-Inflammation and NADPH Oxidase 2.

Authors:  Emma J Arsenault; Colin M McGill; Brian M Barth
Journal:  Neuromolecular Med       Date:  2021-02-05       Impact factor: 4.103

8.  Imaging Mass Spectrometry Reveals Acyl-Chain- and Region-Specific Sphingolipid Metabolism in the Kidneys of Sphingomyelin Synthase 2-Deficient Mice.

Authors:  Masayuki Sugimoto; Masato Wakabayashi; Yoichi Shimizu; Takeshi Yoshioka; Kenichi Higashino; Yoshito Numata; Tomohiko Okuda; Songji Zhao; Shota Sakai; Yasuyuki Igarashi; Yuji Kuge
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

9.  ER residency of the ceramide phosphoethanolamine synthase SMSr relies on homotypic oligomerization mediated by its SAM domain.

Authors:  Birol Cabukusta; Matthijs Kol; Laura Kneller; Angelika Hilderink; Andreas Bickert; John G M Mina; Sergei Korneev; Joost C M Holthuis
Journal:  Sci Rep       Date:  2017-01-25       Impact factor: 4.379

10.  Ceramide phosphoethanolamine synthase SMSr is a target of caspase-6 during apoptotic cell death.

Authors:  Birol Cabukusta; Niclas T Nettebrock; Matthijs Kol; Angelika Hilderink; Fikadu G Tafesse; Joost C M Holthuis
Journal:  Biosci Rep       Date:  2017-07-16       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.